Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Clinical Trial Report
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,323 | Dovepress* | 6,648+ | 690 | 7,338 | |
| PubMed Central* | 675 | 173 | 848 | ||
| Totals | 7,323 | 863 | 8,186 | ||
| *Since 7 May 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar